[1] ROSEN E D,SPIEGELMAN B M.Adipocytes as regulators of energy balance and glucose homeostasis[J].Nature,2006,444(7121):847-853. [2] LIU Y,WANG J,LUO S,ET A L.The roles of PPARγ and its agonists in autoimmune diseases:A comprehensive review[J].Journal of Autoimmunity,2020,113:102510. [3] OHLSSON E,HASEMANN M S,WILLER A,et al.Initiation of MLL-rearranged AML is dependent on C/EBPα[J].Journal of Experimental Medicine,2014,211(1):5-13. [4] WANG H,ZAN L S,WANG H B,et al.Cloning,expression analysis and sequence prediction of the CCAAT/enhancer-binding protein alpha gene of Qinchuan cattle[J].Genetics and Molecular Research,2012,11(2):1651. [5] YUAN E,DUAN X,XIANG L,et al.Aged oolong tea reduces high-fat diet-induced fat accumulation and dyslipidemia by regulating the AMPK/ACC signaling pathway[J].Nutrients,2018,10(2):187. [6] PRENTICE K J,SAKSI J,HOTAMISLIGIL G S.Adipokine FABP4 integrates energy stores and counter regulatory metabolic responses[J].Journal of Lipid Research,2019,60(4):734-740. [7] CHEN J,YI L,TIAN M,et al.Molecular mechanisms of FOXO1 in adipocyte differentiation[J].Journal of Molecular Endocrinology,2019,62(3):R239-R253. [8] BURKHARD R,TOH S A,LAGOR W R,et al.Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice[J].Journal of Clinical Investigation,2010,120(12):4410-4414. [9] ALAGAWANY M,ELNESR S S,FARAG M R,et al.Use of licorice (Glycyrrhiza glabra) herb as a feed additive in poultry:Current knowledge and prospects[J].Animals,2019,9(8):536. [10] 伟 唯,江 培.葛根素药理作用研究进展[J].黑龙江医药,2014,27(1):51-55. WEI W,JIANG P.Progress of research on puerarin pharmacological action[J].Heilongjiang Medicine Journal,2014,27(1):51-55.(in Chinese) [11] 楚纪明,马树运,李海峰,等.葛根有效成分及其药理作用研究进展[J].食品与药品,2015,17(2):142-146. CHU J M,MA S Y,LI H F,et al.Progress in effective components and pharmacological effects of Puerariae Lobatae Radix[J].Food and Drug,2015,17(2):142-146.(in Chinese) [12] TAN C,WANG A,LIU C,et al.Puerarin improves vascular insulin resistance and cardiovascular remodeling in salt-sensitive hypertension[J].The American Journal of Chinese Medicine,2017,45(6):1169-1184. [13] LIU Y,QIU Y,CHEN Q,et al.Puerarin suppresses the hepatic gluconeogenesis via activation of PI3K/Akt signaling pathway in diabetic rats and HepG2 cells[J].Biomedicine & Pharmacotherapy,2021,137(3):111325. [14] WANG C,YAO J,JU L,et al.Puerarin ameliorates hyperglycemia in HFD diabetic mice by promoting β-cell neogenesis via GLP-1R signaling activation[J].Phytomedicine,2020,70:153222. [15] 云巾宴,于永生,曹 阳,等.葛根素对Akt通路调控3T3-L1脂肪细胞分化的影响[J].中国畜牧兽医,2018,45(1):57-64. YUN J Y,YU Y S,CAO Y,et al.Effect of puerarin on regulation adipocytes differentiation through Akt pathway in 3T3-L1 cells[J].China Animal Husbandry & Veterinary Medicine,2018,45(1):57-64.(in Chinese) [16] LEE O H,SEO D H,PARK C S,et al.Puerarin enhances adipocyte differentiation,adiponectin expression,and antioxidant response in 3T3-L1 cells[J].Biofactors,2010,36(6):459-467. [17] JIAO Y,X LIANG,HOU J,et al.Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K/Akt/FOXO1/PPARγ signaling pathway[J].Lipids in Health and Disease,2019,18(1):70. [18] 耿丽莎,何军华.转录因子FOXO1在糖脂代谢及肥胖症中的研究进展[J].医学综述,2020,26(24):149-153. GENG L S,HE J H.Research progress of transcription factor FOXO1 in glycolipid metabolism and obesity[J].Medical Recapitulate,2020,26(24):149-153.(in Chinese) [19] HOU B Y,ZHAO Y R,MA P,et al.Hypoglycemic activity of puerarin through modulation of oxidative stress and mitochondrial function via AMPK[J].Chinese Journal of Natural Medicines,2020,18(11):818-826. [20] NICHOLAS S,RECTOR R,GRACE U,et al.High intrinsic aerobic capacity protects against ethanol-induced hepatic injury and metabolic dysfunction:Study using high capacity runner rat model[J].Biomolecules,2015,5(4):3295-3308. [21] 林志健,张 冰,刘小青.AMPK-ACC信号通路与相关代谢疾病的研究进展[J].中国糖尿病杂志,2013,21(5):474-477. LIN Z J,ZHANG B,LIU X Q,et al.Advances of researches on AMPK-ACC signaling pathway in metabolic diseases[J].Chinese Journal of Diabetes,2013,21(5):474-477.(in Chinese) [22] FURUHASHI M,SAITOH S,SHIMAMOTO K,et al.Fatty acid-binding protein 4 (FABP4):Pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases[J].Clinical Medicine Insights Cardiology,2015,2014(Suppl 3):23-33. |